STAAR Surgical Company

STAA Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 111.0%, EPS grew 147.1% and free cash flow grew 166.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

21.27 0.99 −4.45%
Market cap
$1.1B
P/E
304×
Fwd P/E
103×
Dividend yield
—
F-score
2/9
Altman Z
6.44
Beneish M
−3.29
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
82.43 90.61 123.95 150.19 163.46 230.47 284.39 322.42 313.90 239.44
Revenue Growth
6.88% 9.92% 36.80% 21.16% 8.84% 41.00% 23.40% 13.37% (2.64%) (23.72%)
Cost of Revenue
24.06 26.33 32.44 38.23 45.10 51.84 61.01 69.76 74.32 57.02
Gross Profit
58.37 64.28 91.51 111.95 118.36 178.64 223.38 252.65 239.58 182.42
R&D Expenses
20.67 20.04 22.03 25.30 31.92 33.86 35.98 40.48 45.32 40.06
SG&A Expenses
50.36 47.87 62.89 74.80 79.68 111.44 143.60 184.08 206.88 188.31
Operating Income
(12.65) (3.63) 6.60 11.85 6.77 33.34 43.80 28.10 (12.61) (91.71)
Non-operating Income/Expense
0.21 1.34 0.04 1.17 1.50 (2.03) 1.75 5.60 3.56 9.45
EBT
(12.44) (2.30) 6.64 13.03 8.27 31.30 45.55 33.70 (9.05) (82.26)
Income Tax Provision
(0.31) (0.16) 1.67 (1.02) 2.35 3.79 5.89 12.35 11.16 (1.81)
Income after Tax
(12.13) (2.14) 4.97 14.05 5.91 27.51 39.67 21.35 (20.21) (80.45)
Dividends (Preferred)
0.00 — — — — 0.00 0.00 — — —
Net Income Common
(12.13) (2.14) 4.97 14.05 5.91 27.51 39.67 21.35 (20.21) (80.45)
EPS (Basic)
(0.30) (0.05) 0.12 0.32 0.13 0.52 0.81 0.44 (0.41) (1.62)
EPS (Diluted)
(0.30) (0.05) 0.11 0.30 0.12 0.50 0.78 0.43 (0.41) (1.62)
Shares (Basic, Weighted)
40.33 41.00 42.59 44.49 45.61 47.21 47.99 48.52 49.13 49.57
Shares (Diluted, Weighted)
40.33 41.00 45.26 46.90 47.95 49.46 49.38 49.43 49.13 49.57
Gross Margin
70.81% 70.94% 73.83% 74.54% 72.41% 77.51% 78.55% 78.36% 76.32% 76.19%
EBIT Margin
(15.35%) (4.01%) 5.32% 7.89% 4.14% 14.47% 15.40% 8.71% (4.02%) (38.30%)
EBT margin
(15.10%) (2.53%) 5.36% 8.67% 5.06% 13.58% 16.02% 10.45% (2.88%) (34.36%)
Net Profit Margin
(14.71%) (2.36%) 4.01% 9.35% 3.62% 11.94% 13.95% 6.62% (6.44%) (33.60%)
Free Cash Flow Margin
(2.62%) 1.99% 8.49% 10.40% 7.68% 13.15% 6.19% (1.11%) (2.44%) (16.73%)
EBITDA
(9.76) (0.28) 9.06 15.55 9.86 36.98 47.11 30.72 (6.81) (83.18)
EBIT
(12.65) (3.63) 6.60 11.85 6.77 33.34 43.80 28.10 (12.61) (91.71)
Income from Continuous Operations
(12.13) (2.14) 4.97 14.05 5.91 27.51 39.67 21.35 (20.21) (80.45)
Consolidated Net Income/Loss
(12.13) (2.14) 4.97 14.05 5.91 27.51 39.67 21.35 (20.21) (80.45)
EPS (Basic, from Continuous Ops)
(0.30) (0.05) 0.12 0.32 0.13 0.58 0.83 0.44 (0.41) (1.62)
EPS (Basic, Consolidated)
(0.30) (0.05) 0.12 0.32 0.13 0.58 0.83 0.44 (0.41) (1.62)
EPS (Diluted, from Cont. Ops)
(0.30) (0.05) 0.11 0.30 0.12 0.56 0.80 0.43 (0.41) (1.62)
Shares (Diluted, Average)
40.33 41.00 45.26 46.90 47.95 49.46 49.38 49.43 49.13 49.57
EPS (Diluted, Consolidated)
(0.30) (0.05) 0.11 0.30 0.12 0.56 0.80 0.43 (0.41) (1.62)
EBITDA Margin
(11.84%) (0.31%) 7.31% 10.35% 6.03% 16.05% 16.57% 9.53% (2.17%) (34.74%)
Operating Cash Flow Margin
1.27% 3.15% 10.30% 17.18% 12.82% 19.07% 12.56% 4.53% 5.01% (14.30%)

Fold the line items

In millions of $ except per-share values · columns are period end dates